Who is sponsoring MXMIN-001?

MXMIN-001 is sponsored by Darier.

What condition does MXMIN-001 study?

MXMIN-001 studies Mild to Moderate Acne.

What drugs are being tested in MXMIN-001?

Interventions: Minocycline vs Lymecycline.

What is the status of MXMIN-001?

MXMIN-001 is currently UNKNOWN.

Last reviewed 2009-09-30 · How we verify

Safety and Efficacy Comparison of Minocycline Microgranules vs Lymecycline in the Treatment of Mild to Moderate Acne. Randomized, Double Blind, Parallel and Prospective Clinical Trial for 8 Weeks (MXMIN-001)

NCT00988026 Phase 4 UNKNOWN

This is a clinical trial to compare the benefits and possible adverse events of two antibiotic treatments for mild to moderate acne. It is expected that minocycline microgranules will be more effective than lymecycline with a better adverse events profile.

Details

Lead sponsor	Darier
Phase	Phase 4
Status	UNKNOWN
Enrolment	168
Start date	2009-06
Completion	2010-04

Conditions

Mild to Moderate Acne

Interventions

Minocycline vs Lymecycline

Primary outcomes

Number of inflammatory and non-inflammatory acne lesions — 8 weeks

Countries

Mexico